ARTICLE | Company News
Gruenenthal GmbH, KeyNeurotek deal
March 5, 2007 8:00 AM UTC
KeyNeurotek received exclusive, worldwide rights to develop and commercialize Grunenthal's GRT 203 to treat aconuresis (urinary incontinence) for an undisclosed amount of cash. The small molecule mu ...